Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7704551PMC
http://dx.doi.org/10.1038/s41390-020-01143-5DOI Listing

Publication Analysis

Top Keywords

sarnat score
4
score neonatal
4
neonatal encephalopathy
4
encephalopathy moving
4
moving forward
4
sarnat
1
neonatal
1
encephalopathy
1
moving
1
forward
1

Similar Publications

Towards a histological diagnosis of childhood small vessel CNS vasculitis.

Pediatr Rheumatol Online J

December 2024

Section of Rheumatology, Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, Canada.

Background: Primary small vessel CNS vasculitis (sv-cPACNS) is a challenging inflammatory brain disease in children. Brain biopsy is mandatory to confirm the diagnosis. This study aims to develop and validate a histological scoring tool for diagnosing small vessel CNS vasculitis.

View Article and Find Full Text PDF

Background: Intrapartum-related neonatal encephalopathy (NE) is a leading cause of childhood mortality and morbidity. Continuous electroencephalography (EEG) is gold standard for neonatal brain monitoring; however, low-income country data is lacking. We examined EEG in a Ugandan cohort with NE to describe feasibility, background activity, seizure prevalence and burden, and associations with clinical presentation and outcome.

View Article and Find Full Text PDF
Article Synopsis
  • Forceps delivery is increasingly overlooked in favor of cesarean sections, despite cesarean complications, with concerns primarily focused on safety and long-term effects on children.
  • A study involving 49 women in Serbia assessed the neurological outcomes of children born via forceps at age 7, showing a 16.3% incidence of pathological neurological status among newborns.
  • Long-term issues were found in 6.4% of cases, highlighting that while forceps delivery is generally safe for neurological development, there are still mild disorders that can arise.
View Article and Find Full Text PDF

Aim: A study reported that therapeutic hypothermia (TH) did not reduce the combined prognosis of mortality and disability at 18 months, in low- and middle-income countries for patients with hypoxic ischaemic encephalopathy (HIE) who received TH, suggesting its no implementation in these regions. We described characteristics, mortality, and neurological response before and after the use of TH in newborns with HIE within the EpicLatino Neonatal Network (ENN) and described the population of infants with HIE treated and not treated with TH.

Methods: Data were collected from 2015 to 2022 for patients with HIE.

View Article and Find Full Text PDF

Circulating MicroRNAs as a biomarker signature of perinatal asphyxia.

Pediatr Neonatol

August 2024

Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, Taiwan; Cell Physiology and Molecular Image Research Center, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan. Electronic address:

Aim: This study aimed to explore whether microRNAs (miRNAs) could serve as biomarkers of perinatal asphyxia and whether they were correlated with severity of brain magnetic resonance imaging.

Methods: We prospectively enrolled 26 full-term newborns, including 10 with perinatal asphyxia and 16 healthy controls. Plasma samples were collected at 0-6 h and 7 days of age.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!